» Articles » PMID: 26218581

Venting Gastrostomy at Home for Symptomatic Management of Bowel Obstruction in Advanced/Recurrent Ovarian Malignancy: A Case Series

Overview
Journal J Palliat Med
Specialty Critical Care
Date 2015 Jul 29
PMID 26218581
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant bowel obstruction (MBO) frequently defines the trajectory of end-stage ovarian cancer and results in severe physical and psychological distress in patients and their caregivers. Venting gastrostomy (VG) is an alternative to both prolonged medical therapy with nasogastric intubation and intestinal bypass/diversion for refractory MBO. Limited published data from large academic research centers support use of VG in patients with advanced ovarian cancer and MBO. In this case series, we describe supportive care outcomes in ovarian cancer patients with MBO receiving the effects of VG in a community setting. Six cases of advanced ovarian cancer involving MBO were evaluated for VG from July 2009 through February 2012. Five of six patients were managed with VG. Our experience suggests that VG may be beneficial in controlling nausea and vomiting in ovarian cancer patients with MBO and that VG placement with concurrent evacuation of large-volume ascites was associated with minimal complications. Future prospective studies to evaluate the benefits of VG are warranted.

Citing Articles

CT Fluoroscopy-Guided Percutaneous Gastrostomy in the Palliative Management of Advanced and Relapsed Ovarian Cancer: The Charité Experiences and a Review of the Literature.

Canaz E, Sehouli J, Gebauer B, Segger L, Collettini F, Auer T Cancers (Basel). 2023; 15(18).

PMID: 37760510 PMC: 10526206. DOI: 10.3390/cancers15184540.


Use of a large-diameter 30-French venting gastrostomy tube is effective and safe for symptom palliation in patients with malignant bowel obstruction.

Fejleh M, Chang M, Anand G, Savides T Ann Gastroenterol. 2022; 35(2):177-181.

PMID: 35479596 PMC: 8922254. DOI: 10.20524/aog.2022.0694.


MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.

Madariaga A, Lau J, Ghoshal A, Dzierzanowski T, Larkin P, Sobocki J Support Care Cancer. 2022; 30(6):4711-4728.

PMID: 35274188 PMC: 9046338. DOI: 10.1007/s00520-022-06889-8.


Non-Surgical Management of Malignant Bowel Obstruction in Advanced Ovarian Cancer patients: A Systematic Review and Meta-Analysis.

Idaikkadar P, Georgiou A, Skene S, Michael A Am J Hosp Palliat Care. 2021; 39(7):838-846.

PMID: 34490792 PMC: 9210105. DOI: 10.1177/10499091211043079.


Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer.

Morgan R, Stamatopoulou S, Mescallado N, Saunders G, Welch R, Mitchell C ESMO Open. 2019; 4(2):e000463.

PMID: 30962962 PMC: 6435240. DOI: 10.1136/esmoopen-2018-000463.